~~<i id='16BE1E91D2'><strike id='16BE1E91D2'><tt id='16BE1E91D2'><pre id='16BE1E91D2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：knowledge 2025-09-29 21:02:36 - browse：66656

The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： There's an unseen cost to disruptive road

leisure time

focus

entertainment

hotspot

focus

explore

AdobeWASHINGTON—FoodandDrugAdministrationofficialshopetofinishthisyearamassiveoverhaulofthewaytheage

WSS

How a symptom of dementia informs our understanding of creativity

How a symptom of dementia informs our understanding of creativity

How a symptom of dementia informs our understanding of creativity

Head of FDA's diagnostics center, who led through Covid, retires

Printout prescription drug information shouldn’t go digital

What causes osteoarthritis? Researchers study link to brain protein

entertainment

entertainment

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Diversity in medical illustrations gets boost from Chidiebere Ibe

Drug repurposing or repositioning? The language matters

What do new weight loss drugs mean for bariatric surgery?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

As pharma fights Medicare drug negotiation, hospitals, docs silent

Duchenne breakthrough therapy leaves behind pioneering families

NYU Langone launches private ChatGPT for its health care data

After affirmative action ruling, medical educators look to 'holistic review'

NYU Langone launches private ChatGPT for its health care data

focus

How Long Island became the ‘eugenics capital of the world’

Complete sequence of Y chromosome published for first time

FDA sets aggressive timeline for overhauling inspection procedures

Inaction leaves children at risk from dangerous chemotherapy drug

Cardiologists urge adding sexual orientation, gender identity to health records

AstraZeneca bets AAV gene therapy will still deliver the goods

entertainment

hotspot

focus

explore